0 Commentarii
0 Distribuiri
204 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Antibody-Drug Conjugate (ADC) Oncology Market: Trends and Growth OpportunitiesExecutive Summary Antibody-Drug Conjugate (ADC) Oncology Market Research: Share and Size Intelligence CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period The scope of this Antibody-Drug Conjugate...0 Commentarii 0 Distribuiri 232 Views 0 previzualizare
-
Asia Pacific CRO Market - Oncology Trial Demand Driving Specialized CRO Capability DevelopmentMarket Overview The Asia Pacific contract research organization market is experiencing significant growth from oncology clinical trial activity as Asia Pacific's large cancer patient populations and established oncology research infrastructure attract increasing global and regional pharmaceutical oncology development investment. The Asia Pacific CRO market is projected to surpass USD 12...0 Commentarii 0 Distribuiri 41 Views 0 previzualizare
-
Cancer Research Breakthrough: Evaluating the Critical Role of Spheroids and Organoids in Personalized Oncology and Therapy Development.For 3D cell culture models to transition from specialized research tools to mainstream industry standards in pharmaceutical R&D, they must be scalable for High-Throughput Screening (HTS). The inherent complexity and manual handling requirements of 3D cultures—such as precise media changes, matrix embedding, and complex imaging—initially made them difficult to integrate into the...0 Commentarii 0 Distribuiri 820 Views 0 previzualizare
-
CD47 Targeting Therapeutics Market Analysis and Immuno-Oncology LandscapeThe CD47 Targeting Therapeutics Market analysis highlights the growing significance of CD47 as a promising target in cancer immunotherapy. CD47, often referred to as the “don’t eat me” signal, is overexpressed in many cancer cells, allowing them to evade immune system clearance. Therapeutics targeting CD47 aim to block this signal, enabling macrophages to recognize and...0 Commentarii 0 Distribuiri 478 Views 0 previzualizare
-
CDx Beyond Oncology: Expanding into Rare Diseases and Neurodegenerative Disorders – New Market FrontiersCompanion diagnostics (CDx) are transcending their oncology roots, expanding into new disease areas like rare genetic disorders and neurodegenerative conditions, where precise patient stratification is critical. This shift is driven by advancements in biomarker discovery and growing demand for personalized treatments in underserved fields. As CDx proves its utility beyond cancer, the market is...0 Commentarii 0 Distribuiri 910 Views 0 previzualizare
-
Chemotherapy Drug Market Advances Through Continuous Oncology Treatment Innovations" According to the latest report published by Data Bridge Market Research, the Chemotherapy Drug Market CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. Chemotherapy Drug Marketing report...0 Commentarii 0 Distribuiri 103 Views 0 previzualizare
-
Chemotherapy Drug Market Progresses with Continuous Oncology Treatment Developments" According to the latest report published by Data Bridge Market Research, the Chemotherapy Drug Market CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. Market definition mentioned in this...0 Commentarii 0 Distribuiri 52 Views 0 previzualizare
-
Companion Diagnostics Market - Oncology Pipeline Expansion Accelerating Companion Diagnostic DemandMarket Overview The global companion diagnostics market is expanding rapidly as oncology drug pipelines proliferate and targeted therapy approvals increasingly mandate paired diagnostic validation. The global companion diagnostics market is expected to exceed USD 10 billion through 2030, driven by surging cancer incidence globally, growing pharmaceutical investment in targeted biologics...0 Commentarii 0 Distribuiri 49 Views 0 previzualizare
-
Global Immuno-Oncology Assay Market Forecast 2030: Growth Trends, Key Players & Future Outlook | MarkNtelAs per MarkNtel Advisors The Global Immuno-Oncology Assay Market size was valued at around USD 3.62 billion in 2024 and is projected to reach USD 6.86 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.25% during the forecast period, i.e., 2025-30. Global Immuno-Oncology Assay Market Systems Market Outlook: The Russian Seed Market is rapidly...0 Commentarii 0 Distribuiri 778 Views 0 previzualizare
-
Hadron Therapy Market Growth Driven by Demand for Targeted Oncology SolutionsThe continuous advancement in targeted cancer therapy solutions has placed hadron-based radiation techniques at the forefront of next-generation oncology care. The Hadron Therapy Market research shows that proton and carbon-ion therapies are expanding rapidly due to their superior delivery accuracy and reduced side effects compared to conventional radiotherapy. As the global burden of cancer...0 Commentarii 0 Distribuiri 945 Views 0 previzualizare
-
Harnessing Quantitative Information for Strategic Decisions: Analyzing China Companion Diagnostics Oncology Market DataThe effective utilization of granular, verified information is the bedrock of successful commercial strategy in China’s oncology diagnostics sector. China Companion Diagnostics Oncology Market Data provides the quantitative backbone necessary to move beyond anecdotal evidence and make evidence-based decisions regarding product development, pricing, and distribution. This data...0 Commentarii 0 Distribuiri 947 Views 0 previzualizare
-
Alpha Emitter Market: Tripling to $3.09 Billion by 2032ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market, projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032, representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Basal Cell Carcinoma Treatment Market Size Projected to Reach USD 8.96 Billion by 2032The global Basal Cell Carcinoma Treatment Market comprises the diagnosis and management solutions for Basal Cell Carcinoma, the most common form of skin cancer worldwide. BCC arises from the uncontrolled growth of basal cells, typically appearing on sun-exposed areas of the skin. Treatment modalities range from surgical removal for localized lesions to pharmacological agents and radiation...0 Commentarii 0 Distribuiri 833 Views 0 previzualizare
-
Cell Therapy Manufacturing Market: Global Growth & AnalysisIntrospective Market Research, a global authority in biotechnology and healthcare analysis, today released its comprehensive report on the Global Cell Therapy Manufacturing Market. This critical sector, which encompasses the complex processes of cell acquisition, culture, expansion, and testing for regenerative medicine, is transitioning from a niche laboratory process to an industrialized...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Clinical Nutrition Market - Industry Growth & Trend AnalysisIntrospective Market Research, a leader in specialized healthcare market intelligence, today announced the release of its definitive report on the Global Clinical Nutrition Market. This critical sector, which ensures patients receive necessary dietary support during illness and recovery, was valued at USD 30.13 Billion in 2023. With chronic diseases and an increasing geriatric population...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Colorectal Cancer Treatment Market Advances with Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Colorectal Cancer Treatment Market Progresses with Advances in Targeted and ImmunotherapiesRegional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
DNA Sequencing Market - Latest Advancement And AnalysisIntrospective Market Research, a global provider of specialized market intelligence, today released a pivotal study on the global DNA Sequencing Market. The report reveals a genomic revolution underway, driven by a dramatic reduction in sequencing costs and the increasing integration of sophisticated bioinformatics. The market, which stood at USD 11.1 Billion in 2023, is forecast to reach USD...0 Commentarii 0 Distribuiri 2K Views 0 previzualizare
-
Global Clinical NGS Testing Market Surges with Precision Medicine Growth and Faster Genetic DiagnosticsDetailed Analysis of Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period With this Clinical...0 Commentarii 0 Distribuiri 965 Views 0 previzualizare
-
Global Colorectal Cancer Treatment Market Advances with Targeted Therapies, Immunotherapy, and Early DiagnosisComprehensive Outlook on Executive Summary Colorectal Cancer Treatment Market Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. The insights provided in this Colorectal Cancer Treatment Market research...0 Commentarii 0 Distribuiri 820 Views 0 previzualizare
-
How Are New Therapies Transforming Treatment in Hodgkin Lymphoma?Global Executive Summary Hodgkin Lymphoma Drug Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 The global Hodgkin Lymphoma Drug Market analysis report gives a careful overview of the research trends for the financial year. This report studies the...0 Commentarii 0 Distribuiri 643 Views 0 previzualizare
Sponsorizeaza Paginile
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
